Literature DB >> 17442307

Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.

Sivasakthivel Thirugnanam1, Pandurangan Pandiaraja, Kalyanasundaram Ramaswamy, Vadivel Murugan, Munirathinam Gnanasekar, Krithika Nandakumar, Maryada Venkata Rami Reddy, Perumal Kaliraj.   

Abstract

Immunization of jirds with Bm-alt-2 elicited partial protection against challenge infection with the filarial parasite Brugia malayi. In this study, we initially compared the protective immune responses elicited following immunization with recombinant Bm-ALT-2 protein regimen and Bm-alt-2 DNA regimen. These studies showed that protein vaccination conferred approximately 75% protection compared to DNA vaccination that conferred only 57% protection. Analysis of the protective immune responses showed that the protein immunization promoted a Th2-biased response with an increase in IL-4, IL-5 and IgG1 responses, whereas, the DNA vaccine promoted a Th1-biased response with profound IFN-gamma and IgG2a responses. Since protein vaccination gave better results than DNA vaccination, we then wanted to evaluate whether a prime-boost vaccination that combined DNA prime and protein boost will significantly increase the protective responses induced by the protein vaccine. Our results suggest that prime-boost vaccination had no added advantage and was comparatively less effective (64% protection) than the Bm-ALT-2 protein alone vaccination. Prime boost vaccination generated mixed Th1/Th2 responses with a slightly diminished Th2 responses compared to protein vaccination. Thus, our results suggest that Bm-ALT-2 protein vaccination regimen may be slightly better than prime-boost vaccine regimen and the mechanism of protection appears to be largely mediated by a Th2-biased response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442307      PMCID: PMC2763209          DOI: 10.1016/j.exppara.2007.02.017

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  39 in total

1.  Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.

Authors:  C F Curtis; M Malecela-Lazaro; R Reuben; C A Maxwell
Journal:  Ann Trop Med Parasitol       Date:  2002-12

Review 2.  Mass drug treatment for lymphatic filariasis and onchocerciasis.

Authors:  David H Molyneux; Mark Bradley; Achim Hoerauf; Dominique Kyelem; Mark J Taylor
Journal:  Trends Parasitol       Date:  2003-11

3.  Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.

Authors:  Qing-Min Wang; Shu-Han Sun; Zhen-Lin Hu; Ming Yin; Cun-Jie Xiao; Jian-Cheng Zhang
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

4.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.

Authors:  T R Jones; D L Narum; A S Gozalo; J Aguiar; S R Fuhrmann; H Liang; J D Haynes; J K Moch; C Lucas; T Luu; A J Magill; S L Hoffman; B K Sim
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

6.  Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting.

Authors:  H Martin Vordermeier; Douglas B Lowrie; R Glyn Hewinson
Journal:  Vet Microbiol       Date:  2003-06-10       Impact factor: 3.293

7.  Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages.

Authors:  Lars Volkmann; Odile Bain; Michael Saeftel; Sabine Specht; Kerstin Fischer; Frank Brombacher; Klaus I Matthaei; Achim Hoerauf
Journal:  Med Microbiol Immunol       Date:  2002-12-10       Impact factor: 3.402

8.  Expression and immune recognition of Brugia malayi VAL-1, a homologue of vespid venom allergens and Ancylostoma secreted proteins.

Authors:  J Murray; W F Gregory; N Gomez-Escobar; A K Atmadja; R M Maizels
Journal:  Mol Biochem Parasitol       Date:  2001-11       Impact factor: 1.759

9.  Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses.

Authors:  Sampa Santra; Dan H Barouch; Birgit Korioth-Schmitz; Carol I Lord; Georgia R Krivulka; Faye Yu; Margaret H Beddall; Darci A Gorgone; Michelle A Lifton; Ayako Miura; Valerie Philippon; Kelledy Manson; Phillip D Markham; John Parrish; Marcelo J Kuroda; Jörn E Schmitz; Rebecca S Gelman; John W Shiver; David C Montefiori; Dennis Panicali; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

10.  Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors:  Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more
  30 in total

1.  Granuloma formation around filarial larvae triggered by host responses to an excretory/secretory antigen.

Authors:  Yashodhara Dash; Manish Ramesh; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam; Leonard D Shultz; T V Rajan
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 2.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco.

Authors:  Mathangi Ganapathy; Adhiseshan Perumal; Chakravarthi Mohan; Harunipriya Palaniswamy; Kaliraj Perumal
Journal:  Plant Cell Rep       Date:  2013-11-07       Impact factor: 4.570

4.  Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Authors:  Surianarayanan Bhuvanesh; Chakkaravarthi Arunkumar; Perumal Kaliraj; Subramanian Ramalingam
Journal:  J Ind Microbiol Biotechnol       Date:  2010-07-01       Impact factor: 3.346

5.  Multivalent fusion protein vaccine for lymphatic filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Abhilash Kumble Samykutty; Gnanasekar Munirathinam; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2012-10-02       Impact factor: 3.641

6.  Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.

Authors:  Vikas Kushwaha; Prachi Tewari; Payal Mandal; Anurag Tripathi; P Kalpana Murthy
Journal:  Parasitol Res       Date:  2019-05-04       Impact factor: 2.289

7.  Cytokines, Antibodies, and Histopathological Profiles during Giardia Infection and Variant-Specific Surface Protein-Based Vaccination.

Authors:  Marianela C Serradell; Pablo R Gargantini; Alicia Saura; Sergio R Oms; Lucía L Rupil; Luciana Berod; Tim Sparwasser; Hugo D Luján
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

8.  Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.

Authors:  Christiana Immanuel; Aparnaa Ramanathan; Malathi Balasubramaniyan; Vishal Kishor Khatri; Nitin Purushottam Amdare; Donthamsetty Nageswara Rao; Maryada Venkata Rami Reddy; Kaliraj Perumal
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

9.  Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.

Authors:  Gajalakshmi Dakshinamoorthy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

10.  SXP-RAL Family Filarial Protein, rWbL2, Prevents Development of DSS-Induced Acute Ulcerative Colitis.

Authors:  Namdev S Togre; Priyanka S Bhoj; Vishal K Khatri; Aditya Tarnekar; Kalyan Goswami; Moreshwar R Shende; M V R Reddy
Journal:  Indian J Clin Biochem       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.